Back to top
more

Invesco Leisure and Entertainment ETF: (PEJ)

(Delayed Data from NYSE) As of Feb 27, 2026 04:00 PM ET

$61.73 USD

61.725
17,648

-0.36 (-0.57%)

Volume: 17,648

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

4 - Sell of 5       4  

After-Market: $61.72 -0.01 (-0.01 %) 7:58 PM ET

Zacks News

Sanghamitra Saha headshot

4 Sector ETFs to Play Despite Soft December Jobs Data

The U.S. economy added 199, 000 jobs in December 2021, well below market forecasts of 400,000.

Sweta Jaiswal, FRM headshot

ETFs to Play the Reopening Trade as Omicron Fear Subsides

The improved market sentiments have been leading to greater attention and confidence in reopening trades.

Sanghamitra Saha headshot

5 Sector ETFs To Win Despite Weak November Jobs Data

Non-farm payrolls increased by 210,000 in November following a gain of 546,000 the previous month. The number fell shy of Wall Street expectations of 573,000, per CNBC.

Sanghamitra Saha headshot

A Spread of ETFs to Dig Into On Thanksgiving

While Thanksgiving dinner is costlier this year, thanksgiving travel will likely gain speed. These ETFs should benefit of this trend.

Sanghamitra Saha headshot

5 Sector ETFs to Play Robust October Jobs Data

The U.S. economy added 531,000 jobs in October 2021, the maximum in three months.

Zacks Equity Research

Is Invesco Dynamic Leisure and Entertainment ETF (PEJ) a Strong ETF Right Now?

Smart Beta ETF report for PEJ

Sanghamitra Saha headshot

5 Sector ETFs to Benefit Despite Downbeat September Jobs Data

The U.S. economy added 194,000 jobs in September 2021, the lowest so far this year and well below forecasts of 500,000.

Sweta Jaiswal, FRM headshot

ETFs to Play the Reopening Trade on Merck's Oral Antiviral Pill News

Let's take a look at ETFs that are well-poised to gain as the reopening of the U.S. economy may pick up further pace following Merck's announcement.